37 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 22607579 | Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects. | 2012 Jul | 1 |
2 | 12063974 | Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis? | 2002 May-Jun | 1 |
3 | 12503773 | Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level. | 2002 | 2 |
4 | 9068463 | Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. | 1997 Mar | 1 |
5 | 8804870 | Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. | 1996 May | 1 |
6 | 7875420 | [Variations of plasma gastrin (basal and postprandial) in ththtreatmentof duodenal ulcer with either enprostil or ranitidine. Correlations with rates of relapse]. | 1994 | 2 |
7 | 8053433 | Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. | 1994 Aug | 1 |
8 | 8180296 | Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. | 1994 | 1 |
9 | 8281874 | Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration. | 1994 Jan | 1 |
10 | 8101695 | Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. | 1993 Aug | 1 |
11 | 8285777 | Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. | 1993 Dec | 1 |
12 | 8472980 | Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. | 1993 Mar | 2 |
13 | 8490080 | An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. | 1993 | 1 |
14 | 1427586 | Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients. | 1992 Aug | 2 |
15 | 1736336 | Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients. | 1992 | 1 |
16 | 1675024 | Is hypergastrinaemia dangerous to man? | 1991 | 1 |
17 | 1685675 | Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine. | 1991 Aug | 1 |
18 | 1862300 | 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. | 1991 Jun | 1 |
19 | 1889719 | Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study. | 1991 Oct | 1 |
20 | 1983349 | Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man. | 1990 | 1 |
21 | 2093018 | Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. | 1990 | 1 |
22 | 2103756 | Gastric histology and plasma gastrin response to a meal in patients with duodenal ulcer disease after five years treatment with ranitidine. | 1990 Aug | 1 |
23 | 2277968 | High doses of ranitidine in patients with reflux oesophagitis. | 1990 | 2 |
24 | 2390929 | Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans. | 1990 Sep | 2 |
25 | 2513641 | Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. | 1989 | 1 |
26 | 2904394 | Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h. | 1988 Oct | 1 |
27 | 3127265 | Persistence of circadian rhythms in gastric acid, gastrin, and pancreatic polypeptide secretions despite loss of cortisol and body temperature rhythms in man under stress. | 1988 Jan | 1 |
28 | 3410170 | Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. | 1988 | 1 |
29 | 2979226 | Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. | 1987 Jun | 1 |
30 | 2878726 | Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma. | 1986 | 1 |
31 | 3702129 | [Chronological effect of histamine H2 receptor antagonist ranitidine as serum gastrin response in gastric ulcer patients]. | 1986 Jan | 1 |
32 | 3818148 | Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients. | 1986 Dec | 1 |
33 | 2410935 | Effects of eight-week treatment with oral ranitidine on plasma level changes of gastrin, histamine and serotonin in duodenal ulcer patients. | 1985 Jun | 3 |
34 | 2856908 | Effects of cimetidine and ranitidine on interdigestive and postprandial lower esophageal sphincter pressures and plasma gastrin levels in normal subjects. | 1985 Feb | 1 |
35 | 2986474 | The effect of magnesium trisilicate mixture, metoclopramide and ranitidine on gastric pH, volume and serum gastrin. | 1985 Mar | 3 |
36 | 6125203 | Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. | 1982 Aug | 1 |
37 | 6293900 | Effect of gastrin on fasting and postprandial plasma GIP release in man. | 1982 | 1 |